17Sep
17Sep
MTEC Awards $3M to Astrocyte Pharmaceuticals for Clinical Study of AST-004
Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel neuroprotective therapeutics for the treatment of neurodegenerative brain injuries, announced today the granting of a $3.0M award from the Medical Technology Enterprise Consortium (MTEC). Read more >>
15Sep
A Better Surgical Suture: A Development Story
The EasyWhip is indicated for use in approximation and/or ligation of soft tissues, including the use of allograft tissue for orthopedic surgeries. It is ideal for repairing torn ligaments and tendons, like the anterior cruciate ligament (ACL), Achilles’ tendon, and distal biceps tendon. The EasyWhip’s clearance is the first regulatory milestone for Winter Innovations Inc., the company Winter and Dishner (its chief operating officer) founded in 2018. Shortly before gaining FDA clearance this past spring, the company received a $256,000...
15Sep
25 Under 25 – Meet the young entrepreneurs bursting onto the startup scene in Greater Boston.
David Zamarin, 23, founder of DetraPel. David Zamarin became an entrepreneur at just 15, launching a company after discovering what he found to be a lack of safe cleaning products for spills and stains. Zamarin ran a shoe-cleaning business that used a cleaning product that contained dangerous fluorochemicals. Read more >>
15Sep
ZetrOZ Systems’ SAM Ultrasound Device Successfully Treats Elbow Injury for U.S. Tennis Athlete
As a former college tennis player, Kim Dooley suffered elbow injuries throughout her career, including a severed tendon that ended her competitive career. Some 20 years later, hoping to return to the sport, Dooley turned to ZetrOZ Systems' FDA-cleared sustained acoustic medicine (sam®) device. Read more >>
14Sep
AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics), a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes an upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to successfully developed therapeutics. Read more >>
09Sep
Canvas GFX and Aras partner to deliver integration of Aras Innovator and Canvas Envision
Canvas GFX, Inc, the leading provider of visual communication solutions to the manufacturing and technical industries today announced that it has partnered with Aras, provider of a digital transformation platform to enable the resilient enterprise to deliver an integration between Canvas Envision and the Aras innovator platform. The integration enables end users to access data stored on Aras Innovator directly from the Envision Creator desktop graphics application, allowing frictionless creation of product documentation containing rich visualizations of 3D models. Read...
08Sep
Myomo, Inc. Announces Granting of Patents in China and Hong Kong
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the granting of patents in China and Hong Kong covering the Company’s most advanced products. The patents are titled “Powered Orthotic Device and Method of Using Same,” which cover a powered orthotic device that supports movement of a user’s arm about the elbow and a user’s fingers and thumb to support grasping. These newly issued patents are in...
08Sep
Taiwania Capital Joins Pool of Existing Investors to Fund $17 Million of Series B-1 Investment in Novel Drug Delivery Company, Windgap Medical, Inc.
Windgap Medical, Inc., a leading drug delivery platform company, announced today that it has successfully completed initial closing of over $17 million of Series B-1 equity financing round of investment, led by Taiwania Capital. This equity investment round is also supported by existing investors, including Shepherd Kaplan Krochuk, Molex Ventures (a Koch Industries company), and others. Read more >>
08Sep